Ventricular Arrhythmias in Acute Myocardial Infarction
ADVERSE-MI
Ventricular Arrhythmias in the Acute Phase of Myocardial Infarction: ADVERSE MI Study
1 other identifier
observational
500
1 country
8
Brief Summary
Ventricular arrhythmias are a serious complication of myocardial infarction. The aim of this study is to provide reliable data on the management and mortality associated with ventricular arrhythmia in the setting of acute myocardial infarction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Typical duration for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2025
CompletedFirst Submitted
Initial submission to the registry
January 11, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
May 28, 2026
April 1, 2026
1.3 years
January 11, 2026
May 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-discharge mortality
through study completion, an average of 2 years
Secondary Outcomes (9)
Baseline demographic and clinical characteristics at inclusion
At baseline
Number of participants fot each type of myocardial infarction
At baseline
Number of participants with each ventricular arrhythmia characteristic and management strategy during index hospitalization
At baseline
In-hospital mortality
From admission until the date of death or hospital discharge, whichever came first, assessed up to 28 days
Number of participants with wearable cardioverter-defibrillator utilization
At baseline
- +4 more secondary outcomes
Study Arms (1)
Ventricular arrhythmia
patients who developed a sustained ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation) during the acute phase of myocardial infarction, i.e., from infarct onset to hospital discharge
Eligibility Criteria
All included individuals will be consecutive patients who developed a sustained ventricular arrhythmia during the acute phase of a myocardial infarction between January 1, 2012, and April 14, 2024.
You may qualify if:
- ≥ 18 years
- Acute myocardial infarction
- Sustained ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation) at the acute phase of an acute myocardial infarction (before hospital discharge)
- Between January 1, 2012 and April 14, 2024
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
University hospital of Caen
Caen, France
University hospital of Dijon
Dijon, France
University hospital of Grenoble
Grenoble, France
Hopital Européen Georges Pompidou
Paris, France
Hospital of Pau
Pau, France
University hospital of Poitiers
Poitiers, France
University hospital of Saint Etienne
Saint-Etienne, France
University hospital of Tours
Tours, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigue Garcia, MD; PhD
Cardiology department and CIC 1402; University Hospital of Poitiers
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2026
First Posted
April 8, 2026
Study Start
June 20, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2027
Last Updated
May 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share